Quince Therapeutics
Price & Volume
Stats
See moreOpen | $16.56 |
Previous Close | $17.25 |
Day Range | $16.22-$19.01 |
52W Range | $15.10-$910 |
Market Cap | $16.8M |
Shares Short | 112,788 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$210 |
News
See moreYahoo Finance • 2 months ago
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
Yahoo Finance • 2 months ago
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
Yahoo Finance • 4 months ago
BC-Most Active Stocks
Yahoo Finance • 7 months ago
Quince Therapeutics price target raised to $5 from $4 at D. Boral Capital
About
CEO | Dr. Dirk Thye M.D. |
Address | 611 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |